Bethesda Hospital

About: Bethesda Hospital is a healthcare organization based out in Ambur, Tamil Nadu, India. It is known for research contribution in the topics: Population & Helicobacter pylori. The organization has 386 authors who have published 472 publications receiving 15193 citations.

Determination of selenium balance in healthy children by AAS-hydride generation and by INAA technique

Abstract: Total daily Se intake was determined by duplicate diet collection, venous blood samples were taken and urine was collected over 24 h in order to measure selenium input and output in healthy, American and Hungarian children aged 8 to 17 living in Budapest. The American children consumed not only locally processed food. Food samples were weighed, mixed, homogenised and the Se content was determined by Instrumental neutron activation analysis (INAA). The Se concentration of blood, plasma and urine samples was determined by atomic absorption spectrometry-hydride generation (AAS-HG) after wet digestion. Se intake calculated for wet weight was 62±18.5 mg/day in American children. In the Hungarian children the mean Se intake was about 35% less than in the Americans. Se concentrations in plasma were 0.84±0.16, in whole blood 1.13±0.17 mmol l-1 in the Americans, higher than those in healthy Hungarian children (0.64±0.10 and 0.83±0.12 mmol l-1, respectively) of similar age and gender. Urinary Se output calculated ...

Measuring sensory and pain thresholds by Semmes-Weinstein monofilaments in patients with leg ulcers: a pilot study

Abstract: Objective: Pain is a common and disabling symptom in patients with leg ulcers. Clinical quantification of pain mostly depends on subjective pain reports, which do not reveal underlying mechanisms. ...

Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naïve Patients with Type 2 Diabetes: The Observational IGLU-SIT Study.

Abstract: The IGLU-SIT study documented the effectiveness of initiating supplementary prandial insulin treatment (SIT) with insulin glulisine after failure of oral antidiabetic drugs alone in patients with type 2 diabetes (T2DM) in a real-world setting in Germany. The IGLU-SIT study was an open-label, prospective, multicentre, non-interventional study with an observation period of 12 ± 1 months. The primary objective was to determine the proportion of patients reaching their pre-defined glycosylated haemoglobin (HbA1c) goal at 3, 6, 9 and 12 months. Selected secondary objectives were absolute change in HbA1c, a 7-point blood glucose profile, and rate of hypoglycaemia. Data were evaluated overall and by age group (< 65, 65–74 and ≥ 75 years). Overall, 215 patients with T2DM were observed in 64 centres. Baseline HbA1c was 8.3%, and mean HbA1c target was 6.8% (baseline 8.1% and target 6.9% in patients ≥ 75 years). Individual HbA1c target attainment in patients peaked at 38.9% (95% confidence interval [CI] 32.1–46.1%) after 12 months; this was 45.9% in patients aged ≥ 75 years. The mean HbA1c reduction was 1.12 ± 1.05% (p < 0.0001) with only minor differences by age group. A 7-point blood glucose profile revealed significant reductions (p < 0.0001) at all time-points. The rate of confirmed symptomatic hypoglycaemia was 2.2% (95% CI 0.7–5.1) during the 12-month follow-up; rates were increased in patients aged ≥ 75 years (7.0%; 95% CI 1.5–19.1) as were the rates of adverse events (17.8 vs. 6.1%). Initiating SIT with insulin glulisine is an appropriate treatment option in patients whose T2DM is insufficiently controlled. Particular attention should be paid to elderly patients in whom higher attainment rates of treatment target were associated with adverse events. https://awbdb.bfarm.de ; Identifier: 6819; Date of registration: 23.06.2016

Assessing HER2 testing quality in breast cancer (BC): Variables that influence HER2-positivity from a large, multicenter, observational study in Germany.

Abstract: 11062 Background: Despite > 10 years of routine HER2 testing in BC, quality is still an issue. It is often assumed that inter- and intra-laboratory variations in testing quality can be assessed by ...